Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Raman spectroscopy investigation shows that mineral maturity is greater in CD-1 than in C57BL/6 mice distal femurs after sexual maturity.

Fayolle C, Labrune M, Berteau JP.

Connect Tissue Res. 2019 Mar 28:1-11. doi: 10.1080/03008207.2019.1601184. [Epub ahead of print]

PMID:
30922120
2.

Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells.

Oberkampf M, Guillerey C, Mouriès J, Rosenbaum P, Fayolle C, Bobard A, Savina A, Ogier-Denis E, Enninga J, Amigorena S, Leclerc C, Dadaglio G.

Nat Commun. 2018 Jun 8;9(1):2241. doi: 10.1038/s41467-018-04686-8.

3.

Cystic fibrosis-related diabetes is caused by islet loss and inflammation.

Hart NJ, Aramandla R, Poffenberger G, Fayolle C, Thames AH, Bautista A, Spigelman AF, Babon JAB, DeNicola ME, Dadi PK, Bush WS, Balamurugan AN, Brissova M, Dai C, Prasad N, Bottino R, Jacobson DA, Drumm ML, Kent SC, MacDonald PE, Powers AC.

JCI Insight. 2018 Apr 19;3(8). pii: 98240. doi: 10.1172/jci.insight.98240. eCollection 2018 Apr 19.

4.

Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling.

Terra M, Oberkampf M, Fayolle C, Rosenbaum P, Guillerey C, Dadaglio G, Leclerc C.

Cancer Res. 2018 Jun 1;78(11):3014-3026. doi: 10.1158/0008-5472.CAN-17-2719. Epub 2018 Mar 9.

5.

Lack of MHC class II molecules favors CD8+ T-cell infiltration into tumors associated with an increased control of tumor growth.

Chaoul N, Tang A, Desrues B, Oberkampf M, Fayolle C, Ladant D, Sainz-Perez A, Leclerc C.

Oncoimmunology. 2017 Dec 7;7(3):e1404213. doi: 10.1080/2162402X.2017.1404213. eCollection 2018.

6.

Identification of insulin-sensitizing molecules acting by disrupting the interaction between the Insulin Receptor and Grb14.

Gondoin A, Hampe C, Eudes R, Fayolle C, Pierre-Eugène C, Miteva M, Villoutreix BO, Charnay-Pouget F, Aitken DJ, Issad T, Burnol AF.

Sci Rep. 2017 Dec 4;7(1):16901. doi: 10.1038/s41598-017-17122-6.

7.

Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.

Marchand L, Kawasaki-Ogita Y, Place J, Fayolle C, Lauton D, Boulet F, Farret A, Renard E.

J Diabetes Sci Technol. 2017 Sep;11(5):924-929. doi: 10.1177/1932296817700161. Epub 2017 Mar 17.

8.

Impact of tapered-cuff tracheal tube on microaspiration of gastric contents in intubated critically ill patients: a multicenter cluster-randomized cross-over controlled trial.

Jaillette E, Girault C, Brunin G, Zerimech F, Behal H, Chiche A, Broucqsault-Dedrie C, Fayolle C, Minacori F, Alves I, Barrailler S, Labreuche J, Robriquet L, Tamion F, Delaporte E, Thellier D, Delcourte C, Duhamel A, Nseir S; BestCuff Study Group and the BoRéal Network.

Intensive Care Med. 2017 Nov;43(11):1562-1571. doi: 10.1007/s00134-017-4736-x. Epub 2017 Mar 16.

PMID:
28303301
9.

CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.

Sayes F, Pawlik A, Frigui W, Gröschel MI, Crommelynck S, Fayolle C, Cia F, Bancroft GJ, Bottai D, Leclerc C, Brosch R, Majlessi L.

PLoS Pathog. 2016 Jul 28;12(7):e1005770. doi: 10.1371/journal.ppat.1005770. eCollection 2016 Jul.

10.

Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia.

Brent J, Guzman D, Bangs C, Grimbacher B, Fayolle C, Huissoon A, Bethune C, Thomas M, Patel S, Jolles S, Alachkar H, Kumaratne D, Baxendale H, Edgar JD, Helbert M, Hambleton S, Arkwright PD.

Clin Exp Immunol. 2016 Apr;184(1):73-82. doi: 10.1111/cei.12748. Epub 2016 Jan 27.

11.

Impact of tracheal cuff shape on microaspiration of gastric contents in intubated critically ill patients: study protocol for a randomized controlled trial.

Jaillette E, Brunin G, Girault C, Zerimech F, Chiche A, Broucqsault-Dedrie C, Fayolle C, Minacori F, Alves I, Barrailler S, Robriquet L, Tamion F, Delaporte E, Thellier D, Delcourte C, Duhamel A, Nseir S.

Trials. 2015 Sep 25;16:429. doi: 10.1186/s13063-015-0955-z.

12.

Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication.

Chaoul N, Fayolle C, Desrues B, Oberkampf M, Tang A, Ladant D, Leclerc C.

Cancer Res. 2015 Aug 15;75(16):3279-91. doi: 10.1158/0008-5472.CAN-15-0454. Epub 2015 Jun 29.

13.

Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses.

Dadaglio G, Fayolle C, Zhang X, Ryffel B, Oberkampf M, Felix T, Hervas-Stubbs S, Osicka R, Sebo P, Ladant D, Leclerc C.

J Immunol. 2014 Aug 15;193(4):1787-98. doi: 10.4049/jimmunol.1302974. Epub 2014 Jul 14.

14.

Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.

Radermecker RP, Fayolle C, Brun JF, Bringer J, Renard E.

Diabetes Metab. 2013 May;39(3):258-62. doi: 10.1016/j.diabet.2012.12.004. Epub 2013 Mar 19.

15.

Calcium influx rescues adenylate cyclase-hemolysin from rapid cell membrane removal and enables phagocyte permeabilization by toxin pores.

Fiser R, Masin J, Bumba L, Pospisilova E, Fayolle C, Basler M, Sadilkova L, Adkins I, Kamanova J, Cerny J, Konopasek I, Osicka R, Leclerc C, Sebo P.

PLoS Pathog. 2012;8(4):e1002580. doi: 10.1371/journal.ppat.1002580. Epub 2012 Apr 5.

16.

Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.

Rudilla F, Fayolle C, Casares N, Durantez M, Arribillaga L, Lozano T, Villanueva L, Pio R, Sarobe P, Leclerc C, Prieto J, Lasarte JJ.

Vaccine. 2012 Apr 16;30(18):2848-58. doi: 10.1016/j.vaccine.2012.02.052. Epub 2012 Mar 2.

17.

Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice.

Demeure CE, Blanchet C, Fitting C, Fayolle C, Khun H, Szatanik M, Milon G, Panthier JJ, Jaubert J, Montagutelli X, Huerre M, Cavaillon JM, Carniel E.

J Infect Dis. 2012 Jan 1;205(1):134-43. doi: 10.1093/infdis/jir696. Epub 2011 Nov 16.

18.

Actinides and decay products in selected produce and bioindicators in the vicinity of a uranium plant.

Pourcelot L, Boulet B, Le Corre C, de Vismes Ott A, Cagnat X, Loyen J, Fayolle C, Van Hecke W, Martinez B, Petit J, Kaltenmeier R, Gieré R.

J Environ Monit. 2011 May;13(5):1327-36. doi: 10.1039/c1em10041f. Epub 2011 Apr 12.

PMID:
21487575
19.

Isotopic evidence of natural uranium and spent fuel uranium releases into the environment.

Pourcelot L, Boulet B, Le Corre C, Loyen J, Fayolle C, Tournieux D, Van Hecke W, Martinez B, Petit J.

J Environ Monit. 2011 Feb;13(2):355-61. doi: 10.1039/c0em00407c. Epub 2010 Dec 3.

PMID:
21132170
20.

Mus spretus SEG/Pas mice resist virulent Yersinia pestis, under multigenic control.

Blanchet C, Jaubert J, Carniel E, Fayolle C, Milon G, Szatanik M, Panthier JJ, Montagutelli X.

Genes Immun. 2011 Jan;12(1):23-30. doi: 10.1038/gene.2010.45. Epub 2010 Sep 23.

PMID:
20861861
21.

Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis.

Durantez M, Fayolle C, Casares N, Belsue V, Riezu-Boj JI, Sarobe P, Prieto J, Borrás-Cuesta F, Leclerc C, Lasarte JJ.

Vaccine. 2010 Oct 18;28(44):7146-54. doi: 10.1016/j.vaccine.2010.08.070. Epub 2010 Sep 15.

22.

Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope.

Fayolle C, Davi M, Dong H, Ritzel D, Le Page A, Knipping F, Majlessi L, Ladant D, Leclerc C.

Vaccine. 2010 Oct 4;28(42):6930-41. doi: 10.1016/j.vaccine.2010.07.059. Epub 2010 Aug 20.

PMID:
20728521
23.

Delineation and analysis of chromosomal regions specifying Yersinia pestis.

Derbise A, Chenal-Francisque V, Huon C, Fayolle C, Demeure CE, Chane-Woon-Ming B, Médigue C, Hinnebusch BJ, Carniel E.

Infect Immun. 2010 Sep;78(9):3930-41. doi: 10.1128/IAI.00281-10. Epub 2010 Jul 6.

24.

Adenylate cyclase toxin translocates across target cell membrane without forming a pore.

Osickova A, Masin J, Fayolle C, Krusek J, Basler M, Pospisilova E, Leclerc C, Osicka R, Sebo P.

Mol Microbiol. 2010 Mar;75(6):1550-62. doi: 10.1111/j.1365-2958.2010.07077.x. Epub 2010 Feb 23.

25.

Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae.

Putze J, Hennequin C, Nougayrède JP, Zhang W, Homburg S, Karch H, Bringer MA, Fayolle C, Carniel E, Rabsch W, Oelschlaeger TA, Oswald E, Forestier C, Hacker J, Dobrindt U.

Infect Immun. 2009 Nov;77(11):4696-703. doi: 10.1128/IAI.00522-09. Epub 2009 Aug 31.

26.

Characterization of chromosomal regions conserved in Yersinia pseudotuberculosis and lost by Yersinia pestis.

Pouillot F, Fayolle C, Carniel E.

Infect Immun. 2008 Oct;76(10):4592-9. doi: 10.1128/IAI.00568-08. Epub 2008 Aug 4.

27.

Plague reappearance in Algeria after 50 years, 2003.

Bertherat E, Bekhoucha S, Chougrani S, Razik F, Duchemin JB, Houti L, Deharib L, Fayolle C, Makrerougrass B, Dali-Yahia R, Bellal R, Belhabri L, Chaieb A, Tikhomirov E, Carniel E.

Emerg Infect Dis. 2007 Oct;13(10):1459-62. doi: 10.3201/eid1310.070284.

28.

The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.

Eppinger M, Rosovitz MJ, Fricke WF, Rasko DA, Kokorina G, Fayolle C, Lindler LE, Carniel E, Ravel J.

PLoS Genet. 2007 Aug;3(8):e142. Epub 2007 Jul 10.

29.

Gadd45a activation protects melanoma cells from ultraviolet B-induced apoptosis.

Fayolle C, Pourchet J, Caron de Fromentel C, Puisieux A, Doré JF, Voeltzel T.

J Invest Dermatol. 2008 Jan;128(1):196-202. Epub 2007 Aug 16.

30.

A putative DNA adenine methyltransferase is involved in Yersinia pseudotuberculosis pathogenicity.

Pouillot F, Fayolle C, Carniel E.

Microbiology. 2007 Aug;153(Pt 8):2426-34.

PMID:
17660407
31.

A horizontally acquired filamentous phage contributes to the pathogenicity of the plague bacillus.

Derbise A, Chenal-Francisque V, Pouillot F, Fayolle C, Prévost MC, Médigue C, Hinnebusch BJ, Carniel E.

Mol Microbiol. 2007 Feb;63(4):1145-57.

33.

UVB-induced G2 arrest of human melanocytes involves Cdc2 sequestration by Gadd45a in nuclear speckles.

Fayolle C, Pourchet J, Cohen A, Pedeux R, Puisieux A, Caron de Fromentel C, Dorè JF, Voeltzel T.

Cell Cycle. 2006 Aug;5(16):1859-64. Epub 2006 Aug 15.

PMID:
16931908
34.

Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.

Mascarell L, Bauche C, Fayolle C, Diop OM, Dupuy M, Nougarede N, Perraut R, Ladant D, Leclerc C.

Vaccine. 2006 Apr 24;24(17):3490-9. Epub 2006 Feb 21.

PMID:
16524647
35.

Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma.

Pedeux R, Sales F, Pourchet J, Kallassy M, Fayolle C, Boniol M, Severi G, Ghanem G, Nakazawa HN, Autier P, Doré JF.

Eur J Cancer. 2006 Jan;42(2):212-5. Epub 2005 Dec 7.

PMID:
16337788
37.
38.

The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization.

Haicheur N, Benchetrit F, Amessou M, Leclerc C, Falguières T, Fayolle C, Bismuth E, Fridman WH, Johannes L, Tartour E.

Int Immunol. 2003 Oct;15(10):1161-71.

PMID:
13679386
39.

In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.

Guermonprez P, Fayolle C, Rojas MJ, Rescigno M, Ladant D, Leclerc C.

Eur J Immunol. 2002 Nov;32(11):3071-81.

40.

Glycerol and NEFA kinetics in long-term fasting king penguins: phase II versus phase III.

Bernard SF, Fayolle C, Robin JP, Groscolas R.

J Exp Biol. 2002 Sep;205(Pt 17):2745-54.

41.

Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes.

Ghosh MK, Li CL, Fayolle C, Dadaglio G, Murphy A, Lemonnier FA, Roy P, Leclerc C.

Vaccine. 2002 Jun 7;20(19-20):2463-73.

PMID:
12057601
42.

Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.

Fayolle C, Osickova A, Osicka R, Henry T, Rojas MJ, Saron MF, Sebo P, Leclerc C.

J Virol. 2001 Aug;75(16):7330-8.

43.

[Role of the nurse in group therapy of the demented aged].

Albin A, Fayolle C, Bidaud C, Gire P, Sagne A.

Soins Gerontol. 2001 Jan-Feb;(27):23-6. French. No abstract available.

PMID:
11309893
44.

[Therapeutic mediations in psycho-geriatric hospitals].

Albin A, Bidaud C, Fayolle C, Gire P, Gonthier R, Jirtanner C, Sagne A.

Soins Gerontol. 2000 Sep-Oct;(25):40-2. French. No abstract available.

PMID:
11309863
45.

Refeeding signal in fasting-incubating king penguins: changes in behavior and egg temperature.

Groscolas R, Decrock F, Thil MA, Fayolle C, Boissery C, Robin JP.

Am J Physiol Regul Integr Comp Physiol. 2000 Dec;279(6):R2104-12.

46.

Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells.

Guermonprez P, Fayolle C, Karimova G, Ullmann A, Leclerc C, Ladant D.

Methods Enzymol. 2000;326:527-42. No abstract available.

PMID:
11036662
47.

Lipid composition of erythrocytes and thrombocytes of a subantarctic seabird, the king penguin.

Fayolle C, Leray C, Ohlmann P, Gutbier G, Cazenave JP, Gachet C, Groscolas R.

Lipids. 2000 Apr;35(4):453-9.

PMID:
10858031
48.

Lipid composition of blood platelets and erythrocytes of southern elephant seal (Mirounga leonina) and antarctic fur seal (Arctocephalus gazella).

Fayolle C, Leray C, Ohlmann P, Gutbier G, Cazenave JP, Gachet C, Groscolas R.

Comp Biochem Physiol B Biochem Mol Biol. 2000 May;126(1):39-47.

PMID:
10825663
49.

In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitope.

Sebo P, Moukrim Z, Kalhous M, Schaft N, Dadaglio G, Sheshko V, Fayolle C, Leclerc C.

FEMS Immunol Med Microbiol. 1999 Nov;26(2):167-73.

50.

Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.

Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C.

J Immunol. 1999 Apr 1;162(7):4157-62.

Supplemental Content

Loading ...
Support Center